$76 Million Acquisition of Pharmaceutical Company

We represented Footstar, Inc. in connection with the formation of a joint venture to facilitate the acquisition of CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, in a transaction valued at approximately $76 million.  The transaction was financed through a combination of equity and debt.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.